Last reviewed 2026-05-31 · How we verify

OWC MGC cream

One World Cannabis Ltd. · Phase 1 active Small molecule ✓ Verified May 2026

OWC MGC cream is a Small molecule drug developed by One World Cannabis Ltd.. It is currently in Phase 1 development. Also known as: OWC psoriasis cream.

OWC MGC cream is a topical cream being studied for its safety and potential use in the treatment of psoriasis. The exact mechanism of action of OWC MGC cream is currently unknown.

Likelihood of approval

9.6% vs 9.6% industry baseline

If approved by FDA: likely 2033–2036

Steps remaining: Phase 2 → Phase 3 → NDA/BLA submission

Confidence: Medium

Why this estimate

Baseline phase 1 → approval rate +9.6pp
Industry-wide phase 1 drugs reach approval ~9.6% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).

Predicted approval windows by jurisdiction (conditional on FDA approval)

Regulator	Country	Likely year	Lag vs FDA
FDA	US	2033–2036	—
EMA	EU	2034–2037	+0.7 yr
MHRA	GB	2034–2037	+0.7 yr
Health Canada	CA	2034–2038	+0.9 yr
TGA	AU	2034–2038	+1.2 yr
PMDA	JP	2034–2038	+1.5 yr
NMPA	CN	2035–2039	+2.3 yr
MFDS	KR	2034–2038	+1.4 yr
CDSCO	IN	2034–2039	+1.8 yr
ANVISA	BR	2035–2039	+2.3 yr

Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).

Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.

At a glance

Generic name	OWC MGC cream
Also known as	OWC psoriasis cream
Sponsor	One World Cannabis Ltd.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Phase I, Double Blind, Randomized, Placebo Controlled, Maximal Dose Study to Determine the Safety, Tolerability of Topical Cream Containing MGC (Medical Grade Cannabis) in Healthy Volunteers (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

OWC MGC cream CI brief — competitive landscape report
OWC MGC cream updates RSS · CI watch RSS
One World Cannabis Ltd. portfolio CI

Frequently asked questions about OWC MGC cream

What is OWC MGC cream?

OWC MGC cream is a Small molecule drug developed by One World Cannabis Ltd..

Who makes OWC MGC cream?

OWC MGC cream is developed by One World Cannabis Ltd. (see full One World Cannabis Ltd. pipeline at /company/one-world-cannabis-ltd).

Is OWC MGC cream also known as anything else?

OWC MGC cream is also known as OWC psoriasis cream.

What development phase is OWC MGC cream in?

OWC MGC cream is in Phase 1.

Manufacturer: One World Cannabis Ltd. — full pipeline
Also known as: OWC psoriasis cream

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing